# Shrnutí článku

**Zdroj:** [cnbc.com](https://www.cnbc.com/2025/08/26/how-glp-1s-wegovy-zepbound-are-reshaping-the-economy.html)

Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s.
Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to treat type 2 diabetes and obesity by mimicking hormones produced in the gut to suppress a person's appetite and regulate blood sugar.
Since Wegovy first received U.S. approval to treat obesity in 2021, and Zepbound in 2023, the drugs have skyrocketed to fame, bringing …